4//SEC Filing
Lenk Robert P 4
Accession 0001209191-23-054914
CIK 0001095981other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 7:00 AM ET
Size
7.3 KB
Accession
0001209191-23-054914
Insider Transaction Report
Form 4
Lenk Robert P
Director
Transactions
- Purchase
Common Stock
2023-11-08$1.65/sh+5,000$8,250→ 12,961 total - Purchase
Common Stock
2023-11-09$1.59/sh+4,199$6,676→ 17,160 total
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.62 to $1.70 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.59 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
PLUS THERAPEUTICS, INC.
CIK 0001095981
Entity typeother
Related Parties
1- filerCIK 0001362635
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 7:00 AM ET
- Size
- 7.3 KB